|
AU2002365268B2
(en)
*
|
2001-10-24 |
2008-02-28 |
The Regents Of The University Of California |
Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
|
|
DE60324393D1
(en)
|
2002-02-12 |
2008-12-11 |
Univ California |
NONINVASIVE MEASUREMENT OF BIOSYNTHESIS AND DEFROSTING SPEEDS OF BIOLOGICAL MOLECULES WHICH ARE ACCESSIBLE TO A DIRECT SAMPLING, OR NOT EASILY ACCESSIBLE, BY INSTALLING A MARKER IN METABOLIC DERIVATIVES AND KATABOLE PRODUCTS
|
|
DE60336546D1
(en)
*
|
2002-02-21 |
2011-05-12 |
Tokyo Gas Co Ltd |
TEST AGENTS FOR THE ASSESSMENT OF THE PHARMACOLOGICAL ACTIVITY OF A MEDICAMENT AND METHOD AND REAGENT FOR SCREENING A MEDICAMENT WITH EXCELLENT ADMINISTRATIVE EFFECT AND / OR LOW SIDE EFFECT FROM ENZYME, ENZYMIN HIBITORS OR RECEPTOR LIGANDS COMPRISING MEDICAMENTS AND / OR PRODRUGS THEREOF
|
|
BR0307764A
(en)
*
|
2002-02-27 |
2004-12-21 |
Cambridge Isotope Lab Inc |
Methods for assessing alveolar gas exchange, treating respiratory tract disease or infection, and determining the presence of respiratory tract disease or infection, and kit
|
|
WO2004011426A2
(en)
*
|
2002-07-30 |
2004-02-05 |
The Regents Of The University Of California |
Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
|
|
US20060105339A1
(en)
*
|
2002-09-04 |
2006-05-18 |
Marc Hellerstein |
Methods for measuring the rates of replication and death of microbial infectious agents in an infected
|
|
AU2003267283B2
(en)
*
|
2002-09-13 |
2009-09-03 |
The Regents Of The University Of California |
Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
|
|
US20070248540A1
(en)
*
|
2002-09-16 |
2007-10-25 |
The Regents Of The University Of California |
Biochemical methods for measuring metabolic fitness of tissues or whole organisms
|
|
AU2003291731B2
(en)
*
|
2002-11-04 |
2009-09-10 |
The Regents Of The University Of California |
Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
|
|
AU2003902390A0
(en)
*
|
2003-05-16 |
2003-06-05 |
Women's And Children's Hospital |
Non-invasive method of assessing gastrointestinal damage
|
|
US7262020B2
(en)
*
|
2003-07-03 |
2007-08-28 |
The Regents Of The University Of California |
Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
|
|
US20050202406A1
(en)
|
2003-11-25 |
2005-09-15 |
The Regents Of The University Of California |
Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
|
|
TW200538738A
(en)
|
2004-02-20 |
2005-12-01 |
Univ California |
Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
|
|
CA2559095A1
(en)
*
|
2004-03-11 |
2005-09-22 |
The Regents Of The University Of California |
Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
|
|
US20050238577A1
(en)
*
|
2004-03-29 |
2005-10-27 |
The Regents Of The University Of California |
Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
|
|
JP4118918B2
(en)
*
|
2005-02-28 |
2008-07-16 |
シャープ株式会社 |
Signal quality evaluation apparatus, information recording / reproducing apparatus, signal quality evaluation method, recording condition determination method, signal quality evaluation program, and computer-readable recording medium recording the signal quality evaluation program
|
|
TW200711660A
(en)
*
|
2005-06-10 |
2007-04-01 |
Univ California |
Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
|
|
US20080220429A1
(en)
*
|
2006-10-27 |
2008-09-11 |
Tishkoff Sarah A |
Single nucleotide polymorphisms and the identification of lactose intolerance
|
|
US8163074B2
(en)
|
2007-02-06 |
2012-04-24 |
Xerox Corporation |
Phase change inks containing colorant compounds
|
|
US10401318B2
(en)
|
2011-03-14 |
2019-09-03 |
Anastasia Rigas |
Breath analyzer and breath test methods
|
|
JP2014526685A
(en)
|
2011-09-08 |
2014-10-06 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
Metabolic flow measurement, imaging, and microscopy
|
|
EP3435088A1
(en)
|
2011-12-07 |
2019-01-30 |
GlaxoSmithKline LLC |
Methods for determining total body skeletal muscle mass
|
|
US20150250407A1
(en)
*
|
2012-03-14 |
2015-09-10 |
Anastasia Rigas |
Breath analyzer and breath test methods
|
|
US9134319B2
(en)
|
2013-03-15 |
2015-09-15 |
The Regents Of The University Of California |
Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
|
|
EP2946722A1
(en)
|
2014-05-20 |
2015-11-25 |
Sensirion AG |
Portable electronic device for breath sampling
|
|
US12414710B2
(en)
|
2018-12-10 |
2025-09-16 |
Anastasia Rigas |
Breath analyzer devices and breath test methods
|
|
US12150752B2
(en)
|
2018-12-10 |
2024-11-26 |
Anastasia Rigas |
Hydrogen breath analyzer and breath test method
|
|
CN119619037B
(en)
*
|
2025-01-24 |
2025-05-06 |
国家卫生健康委科学技术研究所 |
A novel lactose intolerance assay kit and its application
|